Vera Therapeutics Insider Trades
NASDAQ: VERAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $249.99K
- Sales
- 31 · $11.78M
- Shares bought / sold
- 5.88K / 289.94K
- Net activity
- Net selling $11.5 million
Vera Therapeutics insider activity
Over the last 12 months, Vera Therapeutics insiders reported 51 transactions on SEC Form 4: 1 open-market purchase and 31 sales. Insiders bought $249,985 and sold $11.8 million worth of stock, for net insider selling of $11.5 million. The largest seller was Fordyce Marshall, with $9.7 million in reported sales.
The most recent filing shows Fordyce Marshall (PRESIDENT AND CEO) reporting a transaction in 18,500 shares at $2.90 on Sep 15, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VERA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
VERA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 15, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 18,500 | $684.50K | Form 4 |
| Sep 15, 2026 | Fordyce MarshallPRESIDENT AND CEO | Option exercise | 18,500 | $53.59K | Form 4 |
| Sep 11, 2026 | Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | Option exercise | 5,000 | $19.70K | Form 4 |
| Sep 2, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 18,500 | $649.64K | Form 4 |
| Sep 2, 2026 | Fordyce MarshallPRESIDENT AND CEO | Option exercise | 18,500 | $53.59K | Form 4 |
| Aug 3, 2026 | Boman Nancy LeeChief Regulatory Officer | Award | 44,987 | — | Form 4 |
| Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 2,200 | $95.91K | Form 4 |
| Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 10,500 | $450.01K | Form 4 |
| Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 32,550 | $1.37M | Form 4 |
| Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 1,000 | $40.78K | Form 4 |
| Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 2,200 | $95.91K | Form 4 |
| Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 10,500 | $450.01K | Form 4 |
| Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 32,550 | $1.37M | Form 4 |
| Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 1,000 | $40.78K | Form 4 |
| Jul 7, 2026 | Fordyce MarshallPRESIDENT AND CEO | Option exercise | 46,250 | $133.98K | Form 4 |
| Jun 23, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 88 | $3.38K | Form 4 |
| Jun 23, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 18,412 | $698.39K | Form 4 |
| Jun 23, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 88 | $3.38K | Form 4 |
| Jun 23, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 18,412 | $698.39K | Form 4 |
| Jun 23, 2026 | Fordyce MarshallPRESIDENT AND CEO | Option exercise | 18,500 | $53.59K | Form 4 |
| May 12, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 4,281 | $158.77K | Form 4 |
| May 12, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 14,219 | $520.98K | Form 4 |
| May 12, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 4,281 | $158.77K | Form 4 |
| May 12, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 14,219 | $520.98K | Form 4 |
| May 12, 2026 | Fordyce MarshallPRESIDENT AND CEO | Option exercise | 18,500 | $53.59K | Form 4 |
| Apr 14, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 900 | $40.96K | Form 4 |
| Apr 14, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 7,921 | $353.11K | Form 4 |
| Apr 14, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 14,130 | $616.99K | Form 4 |
| Mar 23, 2026 | Wright-Mitchell JaneChief Legal Officer | Award | 42,403 | — | Form 4 |
| Mar 13, 2026 | Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | Option exercise | 10,000 | $39.40K | Form 4 |
| Feb 23, 2026 | Turner William D.Chief Regulatory Officer | Sale | 2,187 | $91.82K | Form 4 |
| Feb 23, 2026 | JOHNSON DAVID LEEChief Operating Officer | Sale | 2,579 | $108.28K | Form 4 |
| Feb 23, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sale | 16,925 | $710.58K | Form 4 |
| Feb 23, 2026 | Skelton Laurence MatthewChief Commercial Officer | Sale | 1,582 | $66.42K | Form 4 |
| Feb 23, 2026 | Grant SeanCHIEF FINANCIAL OFFICER | Sale | 4,949 | $207.78K | Form 4 |
| Feb 23, 2026 | Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | Sale | 3,117 | $130.86K | Form 4 |
| Feb 23, 2026 | Brenner RobertChief Medical Officer | Sale | 2,151 | $90.31K | Form 4 |
| Feb 4, 2026 | Brenner RobertChief Medical Officer | Award | 25,000 | — | Form 4 |
| Feb 4, 2026 | JOHNSON DAVID LEEChief Operating Officer | Award | 20,000 | — | Form 4 |
| Feb 4, 2026 | Grant SeanCHIEF FINANCIAL OFFICER | Award | 25,000 | — | Form 4 |
| Feb 4, 2026 | Turner William D.Chief Regulatory Officer | Award | 25,000 | — | Form 4 |
| Feb 4, 2026 | Skelton Laurence MatthewChief Commercial Officer | Award | 20,000 | — | Form 4 |
| Feb 4, 2026 | Fordyce MarshallPRESIDENT AND CEO | Award | 68,800 | — | Form 4 |
| Feb 4, 2026 | Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | Award | 10,000 | — | Form 4 |
| Dec 15, 2025 | Turner William D.Chief Regulatory Officer | Sale | 10,000 | $500.77K | Form 4 |
| Dec 15, 2025 | Turner William D.Chief Regulatory Officer | Option exercise | 10,000 | $155.30K | Form 4 |
| Dec 11, 2025 | ENRIGHT PATRICK GDirector | Buy | 5,882 | $249.99K | Form 4 |
| Dec 8, 2025 | Turner William D.Chief Regulatory Officer | Sale | 10,000 | $453.05K | Form 4 |
| Dec 8, 2025 | Turner William D.Chief Regulatory Officer | Option exercise | 10,000 | $155.30K | Form 4 |
| Dec 3, 2025 | Turner William D.Chief Regulatory Officer | Sale | 10,000 | $400.00K | Form 4 |
| Dec 3, 2025 | Turner William D.Chief Regulatory Officer | Option exercise | 10,000 | $155.30K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4